PERSON DIRECTORY
Steve Usdin
Steve Usdin appears in 1 indexed conversation across Biotech Hangout. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
1 EPISODE1 SHOW
Language
Episode 131 - February 14, 2025
Chris GarabedianYaron WerberSam FazeliSteve Usdin
Biotech sentiment has reversed as investors discount financing needs, competition, and distant catalysts.Profits at BeiGene, argenx, Legend, Ascendis, SpringWorks, and eventually Ultragenyx may support valuations only with significant growth or productive R&D reinvestment.Moderna’s cancer-vaccine readout, a possible SpringWorks deal, and FDA and NIH policy changes are catalysts amid liquidity, trial, and review-capacity risks.